X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 2,568 | 1,765 | 1,973 | 28,807 | 1,434 |
| Cost of Goods | 364 | 351 | 326 | 4,716 | 302 |
| Gross Profit | 2,204 | 1,414 | 1,647 | 24,091 | 1,132 |
| Operating Expenses | 26,267 | 29,274 | 28,205 | 34,250 | 37,149 |
| Operating Income | -23,699 | -27,509 | -26,232 | -9,443 | -35,715 |
| Interest Expense | 2,186 | 2,257 | 2,232 | 2,201 | 2,304 |
| Other Income | 1,960 | -79 | 2,760 | 11,960 | -1,544 |
| Pre-tax Income | -23,925 | -29,845 | -25,704 | 316 | -39,563 |
| Income Tax | N/A | -30 | 37 | 34 | 258 |
| Net Income Continuous | -23,925 | -29,815 | -25,741 | 282 | -39,821 |
| Net Income | $-23,925 | $-29,815 | $-25,741 | $282 | $-39,821 |
| EPS Basic Total Ops | 2.25 | -0.69 | -3.47 | 0.04 | -5.93 |
| EPS Basic Continuous Ops | 2.25 | -0.69 | -3.47 | 0.04 | -5.94 |
| EPS Diluted Total Ops | 2.25 | -0.69 | -3.47 | 0.04 | -5.91 |
| EPS Diluted Continuous Ops | 2.25 | -0.69 | -3.47 | 0.04 | -5.91 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.69 | -3.47 | 0.04 | -6.01 |
| EBITDA(a) | $-23,476 | $-27,286 | $-25,877 | $-8,967 | $-35,442 |